Loading company
Latest annual · FY2025
Millions- Total revenues
- 912
- Gross profit
- 779
- Operating income
- 51
- Net income
- 145
- Free cash flow
- 78
Latest quarter · Q3 FY2026
Millions- Total revenues
- 207
- Gross profit
- 178
- Operating income
- (29)
- Net income
- (24)
- Free cash flow
- 39
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- +30.8%
- Revenue, 5 yearsFY2020 to FY2025
- +51.2%
- Net income, 5 yearsFY2020 to FY2025
- n/m
Inspire Medical Systems, Inc. (INSP) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $912 million | $802.8 million | +13.6% | 10-K 2026-02-13 · proof |
| Gross profit | $778.8 million | $679.8 million | +14.6% | 10-K 2026-02-13 · proof |
| Operating income | $51 million | $36.1 million | +41.2% | 10-K 2026-02-13 · proof |
| Net income | $145.4 million | $53.5 million | +171.8% | 10-K 2026-02-13 · proof |
| Cash from operating activities | $117 million | $130.2 million | -10.2% | 10-K 2026-02-13 · proof |
| Free cash flow | $78.5 million | $91.1 million | -13.9% | 10-K 2026-02-13 · proof |
| Total assets | $907.3 million | $808.4 million | +12.2% | 10-K 2026-02-13 · proof |
| Total liabilities | $126.2 million | $118.7 million | +6.3% | 10-K 2026-02-13 · proof |
| Cash and cash equivalents | $104.8 million | $150.2 million | -30.2% | 10-K 2026-02-13 · proof |
- What was Inspire Medical Systems, Inc. (INSP)'s revenue in fiscal 2025?
- Inspire Medical Systems, Inc. (INSP) reported revenue of $912 million for fiscal 2025 (the year ended Dec 31, 2025), against $802.8 million the year before (+13.6%). Source: the 10-K filed with the SEC on Feb 13, 2026. SEC
- What was Inspire Medical Systems, Inc. (INSP)'s gross profit in fiscal 2025?
- Inspire Medical Systems, Inc. (INSP) reported gross profit of $778.8 million for fiscal 2025 (the year ended Dec 31, 2025), against $679.8 million the year before (+14.6%). Source: the 10-K filed with the SEC on Feb 13, 2026. SEC
- What was Inspire Medical Systems, Inc. (INSP)'s operating income in fiscal 2025?
- Inspire Medical Systems, Inc. (INSP) reported operating income of $51 million for fiscal 2025 (the year ended Dec 31, 2025), against $36.1 million the year before (+41.2%). Source: the 10-K filed with the SEC on Feb 13, 2026. SEC
- What was Inspire Medical Systems, Inc. (INSP)'s net income in fiscal 2025?
- Inspire Medical Systems, Inc. (INSP) reported net income of $145.4 million for fiscal 2025 (the year ended Dec 31, 2025), against $53.5 million the year before (+171.8%). Source: the 10-K filed with the SEC on Feb 13, 2026. SEC
- What was Inspire Medical Systems, Inc. (INSP)'s cash from operating activities in fiscal 2025?
- Inspire Medical Systems, Inc. (INSP) reported cash from operating activities of $117 million for fiscal 2025 (the year ended Dec 31, 2025), against $130.2 million the year before (-10.2%). Source: the 10-K filed with the SEC on Feb 13, 2026. SEC
- What was Inspire Medical Systems, Inc. (INSP)'s free cash flow in fiscal 2025?
- Inspire Medical Systems, Inc. (INSP) reported free cash flow of $78.5 million for fiscal 2025 (the year ended Dec 31, 2025), against $91.1 million the year before (-13.9%). Source: the 10-K filed with the SEC on Feb 13, 2026. SEC
- What are Inspire Medical Systems, Inc. (INSP)'s total assets?
- As of Dec 31, 2025, Inspire Medical Systems, Inc. (INSP) reported total assets of $907.3 million, against $808.4 million a year earlier (+12.2%). Source: the 10-K filed with the SEC on Feb 13, 2026. SEC
- What are Inspire Medical Systems, Inc. (INSP)'s total liabilities?
- As of Dec 31, 2025, Inspire Medical Systems, Inc. (INSP) reported total liabilities of $126.2 million, against $118.7 million a year earlier (+6.3%). Source: the 10-K filed with the SEC on Feb 13, 2026. SEC
- What are Inspire Medical Systems, Inc. (INSP)'s cash and cash equivalents?
- As of Dec 31, 2025, Inspire Medical Systems, Inc. (INSP) reported cash and cash equivalents of $104.8 million, against $150.2 million a year earlier (-30.2%). Source: the 10-K filed with the SEC on Feb 13, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:INSP&period_type=annual&limit=5"Information only, not investment advice.